CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners

Wells Fargo began coverage on five biotech stocks on Monday, with only Compass Pathways receiving an ‘Equal-Weight’ rating ...
Investing

Wells Fargo starts WAVE Life Sciences stock, optimistic on tech potential

On Wednesday, Wells Fargo initiated coverage on WAVE Life Sciences (NASDAQ:WVE) stock with an Overweight rating and set a price target of $11.00. The new rating is based on the potential of the ...
Hosted on MSN

Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation

Fintel reports that on November 11, 2025, Wells Fargo maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 178.18% Upside As of ...